ROLE OF VEGF IN ATHEROGENESIS
VEGF 在动脉粥样硬化形成中的作用
基本信息
- 批准号:10671061
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Immunohistochemical studies showed that human early atherosclerotic lesions exhibited intensive vascular endothelial growth factor (VEGF) immunoreactivity in subendothelial macrophage-rich regions of thickened intima. In atherosclerotic plaques, VEGF staining was also observed in foam cell-rich regions adjacent to lipid core or neovascularized basal regions of plaque consisting predominantly of smooth muscle cells. High powered field observation revealed that VEGF was localized in extracellular space as well as macrophage cell surface. These observations suggest the possible involvement of oxidized loe density lipoprtein (Ox-LDL) in the development of human atherosclerosis through VEGF induction in macrophages. We also demonstrated that Ox-LDL upregulated VEGF mRNA expression in RAW 264 cells, monocytic cell line, in a time and concentration dependent manner, and that Ox-LDL stimulated the VEGF protein secretion from the cells.We hypothesized that VEGF in subendothelial macrophage-rich … More regions adjacent to endothelial cells at the luminal surface may participate in the maintenance and repair of the lumen endothelium. To test our hypothesis we examined whether VEGF protects the toxicity of Ox-LDL to cultured endothelial cells derived from bovine aorta (BAECs). BAECs preincubation with VEGF prevented Ox-LDL toxicity in a preincubation time- and VEGF concentration-dependent manner. Incubation of BAECs with VEGF increased intracellular glutathione (GSH) in a time-dependent manner. Combined addition of VEGF and L-buthionine sulfoximine, a GSH synthesis inhibitor, reversed GSH level and the protective effect of VEGF on Ox-LDL-induced cytotoxicity. Placenta growth factor, which ligates to VEGF Fit-1 receptor but not KDR/Flk-1, failed to prevent Ox-LDL toxicity and had no effect on intracellular GSH level. Anti- KDR/Flk-1 antibody completely blocked these activities of VEGF.These results suggest that VEGF prevents Ox-LDL-induced endothelial cell damage via intracellular GSH-dependent mechanism through KDR/Flk-1 receptor. Less
免疫组织化学研究表明,人类早期动脉粥样硬化病变在增厚内膜的内皮下巨噬细胞丰富区域表现出强烈的血管内皮生长因子(VEGF)免疫反应性。在动脉粥样硬化斑块中,在邻近脂质核心的富含泡沫细胞的区域或主要由平滑肌细胞组成的斑块的新生血管基底区域中也观察到 VEGF 染色。高倍视野观察显示VEGF定位于细胞外空间以及巨噬细胞表面。这些观察结果表明,氧化洛伊密度脂蛋白(Ox-LDL)可能通过巨噬细胞中的 VEGF 诱导参与人类动脉粥样硬化的发展。我们还证明,Ox-LDL 以时间和浓度依赖性方式上调 RAW 264 细胞(单核细胞系)中 VEGF mRNA 的表达,并且 Ox-LDL 刺激细胞分泌 VEGF 蛋白。我们假设,在管腔表面邻近内皮细胞的富含内皮下巨噬细胞的区域中的 VEGF 可能参与管腔内皮的维护和修复。为了检验我们的假设,我们检查了 VEGF 是否可以保护 Ox-LDL 对培养的牛主动脉内皮细胞 (BAEC) 的毒性。 BAECs 与 VEGF 预孵育以预孵育时间和 VEGF 浓度依赖性方式防止 Ox-LDL 毒性。 BAEC 与 VEGF 一起孵育会以时间依赖性方式增加细胞内谷胱甘肽 (GSH)。联合添加 VEGF 和 L-丁硫氨酸亚砜亚胺(一种 GSH 合成抑制剂)可逆转 GSH 水平以及 VEGF 对 Ox-LDL 诱导的细胞毒性的保护作用。胎盘生长因子与 VEGF Fit-1 受体连接,但不与 KDR/Flk-1 连接,无法预防 Ox-LDL 毒性,并且对细胞内 GSH 水平没有影响。抗KDR/Flk-1抗体完全阻断了VEGF的这些活性。这些结果表明VEGF通过KDR/Flk-1受体通过细胞内GSH依赖性机制防止Ox-LDL诱导的内皮细胞损伤。较少的
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakayama Shinsuke: "The alpha 1-subunit of smooth muscle Ca^<2+> channel preserves multiple open states induced by depolaruzation."J.of Physiol.. 526. 47-56 (2000)
Nakayama Shinsuke:“平滑肌 Ca^2 通道的 α1 亚基保留了去极化诱导的多种开放状态。”J.of Physiol.. 526. 47-56 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kuzuya Masafumi: "VEGF Protects Toxicity of Oxidized LDL to Endothelial Cell via Intracellular Glutathione-Dependent Mechanism through KDR Receptor"Arteriosclerosis, Thrombosis, and Vascular Biology. (in press). (2001)
Kuzuya Masafumi:“VEGF 通过 KDR 受体通过细胞内谷胱甘肽依赖性机制保护氧化 LDL 对内皮细胞的毒性”动脉硬化、血栓形成和血管生物学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kuzuya Masafumi: "Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice."Diabetologia. (in press). (2001)
Kuzuya Masafumi:“糖化交联抑制在胶原晶格上培养的血管平滑肌细胞中基质金属蛋白酶-2 的活化。”Diabetologia。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Koike Teruhiko: "Activation of MMP-2 by Clostridium difficile Toxin B in bovine smooth muscle cells"Biochem.Biophys.Res.Commun. 277. 43-46 (2000)
Koike Teruhiko:“牛平滑肌细胞中艰难梭菌毒素 B 激活 MMP-2”Biochem.Biophys.Res.Commun。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kuzuya M, Asai T, Kanda S, Maeda K, Cheng XW, Iguchi A.: "Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice."Diabetologia. (in press). (2001)
Kuzuya M、Asai T、Kanda S、Maeda K、Cheng XW、Iguchi A.:“糖化交联抑制胶原晶格上培养的血管平滑肌细胞中基质金属蛋白酶 2 的活化。”糖尿病学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUZUYA Masafumi其他文献
KUZUYA Masafumi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUZUYA Masafumi', 18)}}的其他基金
Skeletal muscle regeneration and Sarcopenia therapy: Focusing on the role of GFX
骨骼肌再生和少肌症治疗:关注 GFX 的作用
- 批准号:
15K12699 - 财政年份:2015
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Cathepsin K-Notch signal pathway and sarcopenia
组织蛋白酶 K-Notch 信号通路与肌肉减少症
- 批准号:
15H04801 - 财政年份:2015
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Potential mechanisms and therapeutic strategies of sarcopenia
肌肉减少症的潜在机制和治疗策略
- 批准号:
22390143 - 财政年份:2010
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A multidisciplinary intervention care program to prevent adverse health outcomes for the dependent community-dwelling elderly : a cluster randomized controlled trial.
一项多学科干预护理计划,旨在预防依赖社区居住的老年人的不良健康结果:一项整群随机对照试验。
- 批准号:
21659127 - 财政年份:2009
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Developing useful animal model for investigating the pathophysiological mechanisms of human plaque rupture
开发有用的动物模型来研究人类斑块破裂的病理生理机制
- 批准号:
17590723 - 财政年份:2005
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of Matrix Metalloproteinase in Vascular Remodeling
基质金属蛋白酶在血管重塑中的作用
- 批准号:
13671182 - 财政年份:2001
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Preparation of artificial exosomes containing vascular endothelial cell-derived factors for the treatment of demyelinating diseases
含血管内皮细胞源性因子的人工外泌体的制备用于治疗脱髓鞘疾病
- 批准号:
23K06994 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Restoration of vascular endothelial cell function as a novel strategy to mitigate T2D-associated cardiovascular disease.
恢复血管内皮细胞功能作为减轻 T2D 相关心血管疾病的新策略。
- 批准号:
478125 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Operating Grants
Elucidation of the molecular basis of crosstalk between metabolism and inflammation in vascular endothelial cell activation
阐明血管内皮细胞活化中代谢与炎症之间串扰的分子基础
- 批准号:
22H02891 - 财政年份:2022
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Searching for the mechanisms of vascular endothelial cell differentiation and choroidal neovascularization via B cell-related factor
通过B细胞相关因子寻找血管内皮细胞分化和脉络膜新生血管的机制
- 批准号:
21K09699 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mimicking Vascular Endothelial Cell In Vivo Environment in Cell Culture
在细胞培养中模拟体内环境中的血管内皮细胞
- 批准号:
RGPIN-2017-06336 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Discovery Grants Program - Individual
Investigating the role of vascular endothelial-cell senescence driving resistance to DNA-damaging therapies and metastasis formation in lung cancer
研究血管内皮细胞衰老在肺癌中对 DNA 损伤疗法的抵抗和转移形成中的作用
- 批准号:
MR/V009621/1 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant
Elucidation of the molecular mechanism of N-cadherin in vascular endothelial cell
阐明血管内皮细胞中N-钙粘蛋白的分子机制
- 批准号:
20K17131 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mimicking Vascular Endothelial Cell In Vivo Environment in Cell Culture
在细胞培养中模拟体内环境中的血管内皮细胞
- 批准号:
RGPIN-2017-06336 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Discovery Grants Program - Individual
Pathophysiology of pulmonary arterial hypertension using pulmonary vascular endothelial cell-directed adeno-associated virus.
使用肺血管内皮细胞定向腺相关病毒进行肺动脉高压的病理生理学。
- 批准号:
20K17204 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mimicking Vascular Endothelial Cell In Vivo Environment in Cell Culture
在细胞培养中模拟体内环境中的血管内皮细胞
- 批准号:
RGPIN-2017-06336 - 财政年份:2019
- 资助金额:
$ 1.92万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




